Loading company…
Medibiofarma researches and develops drug candidates for cancer, cognitive decline, and fibrosis.
Medibiofarma is a clinical-stage biotechnology company developing drugs based on clinically validated therapeutic targets. Its pipeline includes candidates for fibrosis, cancer immunotherapy, and neurodegenerative diseases, including MBF-118, MBF-362, MBF-015, and MBF-132. Founded in 2016 by Rodolfo Rodríguez Iglesias, it is based in Navarra, Spain. In March 2022, it received EUR 570,000 in grant funding led by the Center for Technological & Industrial Development.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in